Header Logo

Connection

Michael Jelinek to Protein Kinase Inhibitors

This is a "connection" page, showing publications Michael Jelinek has written about Protein Kinase Inhibitors.
Connection Strength

1.503
  1. Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains? J Clin Oncol. 2019 11 01; 37(31):2807-2814.
    View in: PubMed
    Score: 0.661
  2. Identifying Resistance Mechanisms to Osimertinib via Blood Biopsy. Clin Lung Cancer. 2019 11; 20(6):e597-e600.
    View in: PubMed
    Score: 0.660
  3. Adjuvant Osimertinib: A New Standard of Care. Oncologist. 2021 04; 26(4):263-265.
    View in: PubMed
    Score: 0.181
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.